XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 8,872 $ 4,880
Fixed maturities, current 25,526 26,267
Equity securities 1,503 1,881
Premium receivables 6,682 5,681
Self-funded receivables 3,873 4,010
Other receivables 3,651 3,749
Other current assets 5,496 4,654
Total current assets 55,603 51,122
Long-term investments:    
Fixed maturities, long-term 622 632
Other invested assets 5,516 5,225
Property and equipment, net 4,197 3,919
Goodwill 24,381 24,228
Other intangible assets 10,536 10,615
Other noncurrent assets 2,171 1,719
Total assets 103,026 97,460
Current Liabilities:    
Medical claims payable 15,242 13,518
Other policyholder liabilities 5,482 5,521
Unearned income 3,702 1,153
Accounts payable and accrued expenses 4,963 4,970
Short-term borrowings 265 275
Current portion of long-term debt 2,249 1,599
Other current liabilities 9,384 7,849
Total current liabilities 41,287 34,885
Long-term debt, less current portion 21,258 21,157
Reserves for future policy benefits, noncurrent 825 802
Deferred tax liabilities, net 1,825 2,805
Other noncurrent liabilities 1,788 1,683
Total liabilities 66,983 61,332
Commitments and contingencies – Note 11
Shareholders' equity    
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none 0 0
Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 238,974,624 and 241,770,746 2 2
Additional paid-in capital 9,169 9,148
Retained earnings 29,604 27,088
Accumulated other comprehensive loss (2,784) (178)
Total shareholders' equity 35,991 36,060
Noncontrolling interests 52 68
Total equity 36,043 36,128
Total liabilities and shareholders' equity $ 103,026 $ 97,460